A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i> <i>-</i> Altered Advanced Solid Tumor Malignancies (NCI 10170)
Edward Maldonado(University of California, San Francisco), Rahul Aggarwal(University of California, San Francisco)
Cited by 12
Related Papers
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
|Cancer Research|2022|58